Amyloid β-Protein (35-25) is primarily used in research settings to study the mechanisms of Alzheimer's disease. It is a fragment of the larger amyloid beta protein, which is known to form plaques in the brains of Alzheimer's patients. Researchers utilize this peptide to investigate how these plaques contribute to neuronal damage and cognitive decline. It is also employed in developing and testing potential therapeutic agents aimed at inhibiting plaque formation or promoting their clearance. Additionally, it serves as a tool in understanding the structural and biochemical properties of amyloid beta peptides, aiding in the broader understanding of neurodegenerative diseases.